JBCPL to buy probiotic and reproductive brands from Sanzyme for Rs 628 crore

The acquired portfolio includes Sporlac which is the third largest probiotics brand in India and specialized products such as Lobun - a probiotic used for delaying progression of Chronic Kidney Disease and Oxalo - an alternate risk-free therapy to decalcify kidney stones. The reproductive health segment has a complete range of infertility and hormone products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3H5XK3t
via IFTTT